| Recruiting | A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors Advanced Solid Tumors | Phase 1 | 2026-03-23 |
| Active Not Recruiting | A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Sub Non-small Cell Lung Cancer Stage IV | Phase 3 | 2024-03-12 |
| Active Not Recruiting | A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourc Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage IIIA | Phase 1 | 2024-01-16 |
| Completed | A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO Neovascular Age-related Macular Degeneration, Macular Edema, Retinal Vein Occlusion | Phase 2 | 2023-11-21 |
| Completed | Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Sever Plaque Psoriasis | Phase 4 | 2022-08-04 |
| Completed | A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaqu Psoriasis, Moderate to Severe Plaque Psoriasis | Phase 3 | 2021-07-06 |
| Completed | A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United St Healthy | Phase 1 | 2021-02-04 |
| Completed | A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis Postmenopausal Osteoporosis | Phase 3 | 2020-11-26 |
| Completed | Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Sub Healthy | Phase 1 | 2020-10-19 |
| Completed | Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male Subjects Healthy | Phase 1 | 2020-08-13 |
| Completed | A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Ma Neovascular Age-related Macular Degeneration | Phase 3 | 2020-06-23 |
| Completed | A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haem Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2019-08-07 |
| Completed | Pharmacokinetic, Safety, Tolerability, Immunogenicity, and Pharmacodynamic Study of SB12 in Healthy Subjects Healthy | Phase 1 | 2018-11-13 |
| Completed | A Phase I Study of SB26 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2018-08-22 |
| Completed | A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Age-Related Macular Degeneration | Phase 3 | 2018-03-14 |
| Completed | An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe Rheumatoid Arthritis | Phase 2 | 2017-05-15 |
| Completed | Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Healthy | Phase 1 | 2017-03-24 |
| Completed | A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer Lung Cancer, Non-small Cell Lung Cancer | Phase 3 | 2016-07-05 |
| Terminated | A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed Breast Neoplasms | — | 2016-04-01 |
| Completed | An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syring Rheumatoid Arthritis | Phase 2 | 2015-09-01 |
| Completed | Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy Subjects Healthy | Phase 1 | 2015-06-01 |
| Completed | Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects Healthy | Phase 1 | 2015-04-01 |
| Completed | A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Rheumatoid Arthritis | Phase 3 | 2014-05-01 |
| Completed | Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects Healthy | Phase 1 | 2014-05-01 |
| Completed | A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer HER2 Positive Early or Locally Advanced Breast Cancer | Phase 3 | 2014-04-01 |
| Completed | Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects Healthy | Phase 1 | 2014-02-01 |
| Completed | A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexa Rheumatoid Arthritis | Phase 3 | 2013-08-01 |
| Completed | Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects Healthy | Phase 1 | 2013-07-01 |
| Completed | A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Rheumatoid Arthritis | Phase 3 | 2013-06-01 |
| Completed | Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects Healthy | Phase 1 | 2013-05-01 |